Valuation: CapsoVision, Inc.

Market Cap 306M 268M 248M 229M 434M 29.3B 443M 2.98B 1.16B 14.34B 1.15B 1.12B 49.78B P/E 2026 *
-11.8x
P/E 2027 * -14.6x
Enterprise Value 306M 268M 248M 229M 434M 29.3B 443M 2.98B 1.16B 14.34B 1.15B 1.12B 49.78B EV / Sales 2026 *
19.6x
EV / Sales 2027 * 14.3x
Free-Float
67.91%
Yield 2026 *
-
Yield 2027 * -
1 day+8.02%
1 week-16.89%
Current month-19.20%
1 month-12.75%
3 months-0.24%
6 months-12.50%
Current year-42.70%
1 week 5.62
Extreme 5.62
7.29
1 month 5.62
Extreme 5.62
7.77
Current year 4.5
Extreme 4.5
11.37
1 year 3.43
Extreme 3.4341
15.37
3 years 3.43
Extreme 3.4341
15.37
5 years 3.43
Extreme 3.4341
15.37
10 years 3.43
Extreme 3.4341
15.37
Manager TitleAgeSince
Chief Executive Officer 69 2024-10-31
Director of Finance/CFO 52 -
Corporate Officer/Principal - 2022-02-28
Director TitleAgeSince
Chairman 74 2024-12-31
Director/Board Member 66 2025-06-30
Director/Board Member 62 2025-06-30
Date Insider Type Main position Quantity % Market Cap.
06-30Free

Director

1,710 0.0034%
06-30Other

Director

0 0%
06-29Fiscal year

Director

4,044 0.0081%
Change 5-day change 1-year change 3-year change Capi.($)
+8.02%-16.89%+32.86% - 306M
+1.13%+1.05%-17.93%-27.15% 12.65B
+2.44%-5.91%+85.34%+14.55% 5.07B
-3.92%-1.76%+62.36%+106.45% 1.23B
-0.70%-3.75%-34.86%-63.94% 1.17B
+0.58%-1.51%-39.86%-48.19% 1.08B
-1.15%-3.70%-49.41% - 869M
-0.06%-5.55%+155.21%+143.31% 617M
+2.65%-2.74%-53.35%+226.97% 251M
-0.97%-2.62%-27.61%-44.16% 137M
Average +0.80%-4.86%+11.27%+38.48% 2.34B
Weighted average by Cap. +1.01%-1.12%+10.45%-5.69%

Financials

2026 *2027 *
Net sales 15.58M 13.66M 12.61M 11.65M 22.09M 1.49B 22.53M 152M 58.91M 730M 58.49M 57.21M 2.53B 21.48M 18.84M 17.39M 16.07M 30.46M 2.06B 31.07M 209M 81.23M 1.01B 80.65M 78.88M 3.49B
Net income -24.59M -21.56M -19.91M -18.4M -34.87M -2.35B -35.57M -239M -92.99M -1.15B -92.33M -90.3M -4B -20.36M -17.86M -16.49M -15.23M -28.88M -1.95B -29.45M -198M -77.01M -954M -76.45M -74.78M -3.31B
Net Debt - -
Logo CapsoVision, Inc.
CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
Employees
99
Date Price Change Volume
26-07-08 US$6.125 +8.02% 268,541
26-07-07 US$5.670 -14.22% 367,576
26-07-06 US$6.610 -9.20% 175,356
26-07-02 US$7.280 -1.22% 136,521
26-07-01 US$7.370 -2.77% 162,153
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.125USD
Average target price
10.00USD
Spread / Average Target
+63.27%

Quarterly revenue - Rate of surprise